KMTS
$19.10-0.46 (-2.35%)
Kestra Medical Technologies, Ltd.
Recent News
Kestra Medical Technologies Q3 Earnings Call Highlights
Kestra Medical Technologies (NASDAQ:KMTS) reported what management described as a strong third quarter of fiscal 2026, highlighted by higher prescriptions, accelerating revenue growth, and continued gross margin expansion as the company scales its wearable cardioverter defibrillator (WCD) business a
KESTRA MEDICAL TECHNOLOGIES, LTD. Q3 2026 Earnings Call Summary
Moby summary of KESTRA MEDICAL TECHNOLOGIES, LTD.'s Q3 2026 earnings call
Kestra Medical Technologies Ltd (KMTS) Q3 2026 Earnings Call Highlights: Robust Revenue Growth ...
Kestra Medical Technologies Ltd (KMTS) reports a 63% revenue increase, despite ongoing net losses and strategic investments in market expansion.
Kestra Medical Technologies Ltd (KMTS) Q3 2026: Everything You Need To Know Ahead Of Earnings
This article first appeared on GuruFocus. Kestra Medical Technologies Ltd (NASDAQ:KMTS) is set to release its Q3 2026 earnings on Mar 17, 2026. The consensus estimate for Q3 2026 revenue is $22.86 million, and the earnings are expected to come in at -$0.60 per share.
Institutions along with private equity firms who hold considerable shares inKestra Medical Technologies, Ltd. (NASDAQ:KMTS) come under pressure; lose 6.5% of holdings value
Key Insights Kestra Medical Technologies' significant private equity firms ownership suggests that the key decisions...